T1	intervention 1 10	Parecoxib
T2	total-participants 328 330	40
T3	eligibility 331 395	breast cancer patients undergone the modified radical mastectomy
T4	intervention-participants 444 446	20
T5	control 454 467	control group
T6	control-participants 471 473	20
T9	outcome 912 915	NLR
T10	outcome 1136 1139	NLR
